PTC Therapeutics | PTCT - Gross Profit On Sales



PTC Therapeutics reported $163.39M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 243.83M 19.91M Jun/2025
Alnylam Pharmaceuticals USD 630.74M 107.59M Jun/2025
Amgen USD 6.17B 624M Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
BioMarin Pharmaceutical USD 670.47M 76.89M Jun/2025
Cytokinetics 66.77M 165.03M Jun/2025
Daiichi Sankyo JPY 382.25B 42.1B Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
Incyte USD 1.14B 151.67M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
Ironwood Pharmaceuticals USD 3.65M 60.36M Sep/2024
Novartis USD 11.51B 1.12B Jun/2025
Pfizer USD 10.88B 248M Jun/2025
PTC Therapeutics USD 163.39M 999.84M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sarepta Therapeutics USD 457.87M 149.43M Jun/2025
TG Therapeutics USD 122.21M 16.9M Jun/2025
Ultragenyx Pharmaceutical USD 143.49M 32.86M Jun/2025
Vertex Pharmaceuticals USD 2.56B 150M Jun/2025
Xencor 43.61M 10.88M Jun/2025